TrialPloS one2014

MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.

Marzena Ciechomska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.